Association between higher urinary normetanephrine and insulin resistance in a Japanese population.

Masaya Murabayashi, Makoto Daimon, Hiroshi Murakami, Tomoyuki Fujita, Eri Sato, Jutaro Tanabe, Yuki Matsuhashi, Shinobu Takayasu, Miyuki Yanagimachi, Ken Terui, Kazunori Kageyama, Itoyo Tokuda, Kaori Sawada, Kazushige Ihara

PloS one   15 ( 2 )   e0228787 - e0228787   2020.2

Personality Traits Do Not Have Influence on Glycemic Control in Outpatients with Type 2 Diabetes Mellitus.

Yasui-Furukori N, Murakami H, Otaka H, Tanabe J, Yanagimachi M, Murabayashi M, Matsumura K, Matsuhashi Y, Nakayama H, Mizushiri S, Sugawara N, Daimon M, Shimoda K

Psychiatry investigation   17 ( 1 )   78 - 84   2020.1

Association between higher urinary normetanephrine and insulin resistance in a Japanese population.

Murabayashi M, Daimon M, Murakami H, Fujita T, Sato E, Tanabe J, Matsuhashi Y, Takayasu S, Yanagimachi M, Terui K, Kageyama K, Tokuda I, Sawada K, Ihara K

PloS one   15 ( 2 )   e0228787   2020

Exacerbation of Hyperparathyroidism, Secondary to a Reduction in Kidney Function, in Individuals With Vitamin D Deficiency.

Daimon M, Fujita T, Murabayashi M, Mizushiri S, Murakami H, Nishiya Y, Tanabe J, Matsuhashi Y, Yanagimachi M, Tokuda I, Sawada K, Ihara K

Frontiers in medicine   7   221   2020

Association between insomnia and personality traits among Japanese patients with type 2 diabetes mellitus.

Hideyuki Otaka, Hiroshi Murakami, Hirofumi Nakayama, Masaya Murabayashi, Satoru Mizushiri, Koki Matsumura, Jutaro Tanabe, Yuki Matsuhashi, Miyuki Yanagimachi, Kazutaka Yoshida, Norio Sugawara, Norio Yasui-Furukori, Makoto Daimon

Journal of diabetes investigation   10 ( 2 )   484 - 490   2019.3

Association between insomnia and personality traits among Japanese patients with type 2 diabetes mellitus.

Otaka H, Murakami H, Nakayama H, Murabayashi M, Mizushiri S, Matsumura K, Tanabe J, Matsuhashi Y, Yanagimachi M, Yoshida K, Sugawara N, Yasui-Furukori N, Daimon M

Journal of diabetes investigation   10 ( 2 )   484 - 490   2019.3

Coping behaviors and depressive status in individuals with type 2 diabetes mellitus.

Yasui-Furukori N, Murakami H, Otaka H, Nakayama H, Murabayashi M, Mizushiri S, Matsumura K, Tanabe J, Matsuhashi Y, Yanagimachi M, Nakamura K, Daimon M, Sugawara N

Annals of general psychiatry   18   11   2019

Personality associated with depressive status in individuals with type 2 diabetes mellitus.

Yasui-Furukori N, Murakami H, Otaka H, Nakayama H, Murabayashi M, Mizushiri S, Matsumura K, Tanabe J, Matsuhashi Y, Yanagimachi M, Nakamura K, Daimon M, Sugawara N

Neuropsychiatric disease and treatment   15   1133 - 1139   2019

Lower serum calcium levels are a risk factor for a decrease in eGFR in a general non-chronic kidney disease population.

Satoru Mizushiri, Makoto Daimon, Hiroshi Murakami, Aya Kamba, Sho Osonoi, Masato Yamaichi, Koki Matsumura, Jutaro Tanabe, Yuki Matsuhashi, Miyuki Yanagimachi, Itoyo Tokuda, Shizuka Kurauchi, Kaori Sawada

Scientific reports   8 ( 1 )   14213 - 14213   2018.9

Association between insomnia and coping style in Japanese patients with type 2 diabetes mellitus.

Yoshida K, Otaka H, Murakami H, Nakayama H, Murabayashi M, Mizushiri S, Matsumura K, Tanabe J, Matsuhashi Y, Yanagimachi M, Sugawara N, Nakamura K, Daimon M, Yasui-Furukori N

Neuropsychiatric disease and treatment   14   1803 - 1809   2018

Dominance of the hypothalamus-pituitary-adrenal axis over the renin-angiotensin-aldosterone system is a risk factor for decreased insulin secretion.

Daimon M, Kamba A, Murakami H, Mizushiri S, Osonoi S, Matsuki K, Sato E, Tanabe J, Takayasu S, Matsuhashi Y, Yanagimachi M, Terui K, Kageyama K, Tokuda I, Kurauchi S, Nakaji S

Scientific reports   7 ( 1 )   11360   2017.9

Association between serum prolactin levels and insulin resistance in non-diabetic men.

Daimon M, Kamba A, Murakami H, Mizushiri S, Osonoi S, Yamaichi M, Matsuki K, Sato E, Tanabe J, Takayasu S, Matsuhashi Y, Yanagimachi M, Terui K, Kageyama K, Tokuda I, Takahashi I, Nakaji S

PloS one   12 ( 4 )   e0175204   2017

Association between Higher Serum Cortisol Levels and Decreased Insulin Secretion in a General Population.

Kamba A, Daimon M, Murakami H, Otaka H, Matsuki K, Sato E, Tanabe J, Takayasu S, Matsuhashi Y, Yanagimachi M, Terui K, Kageyama K, Tokuda I, Takahashi I, Nakaji S

PloS one   11 ( 11 )   e0166077   2016

Clinical Significance of Determining Plasma MicroRNA33b in Type 2 Diabetic Patients with Dyslipidemia

Kimura Yuki, Daimon Makoto, Tamasawa Naoki, Matsumura Koki, Murakami Hiroshi, Yamashita Maki, Matsuki Kota, Tanabe Jutaro, Murakami Hiroshi, Matsui Jun

Ｊｏｕｒｎａｌ　ｏｆ　Ａｔｈｅｒｏｓｃｌｅｒｏｓｉｓ　ａｎｄ　Ｔｈｒｏｍｂｏｓｉｓ   23 ( 11 )   1276 - 1285   2016

２型糖尿病患者において高インスリン血症は肥満，脂質異常症，インスリン抵抗性とは独立して血漿アルドステロン濃度上昇に関与している

木村 裕輝, 松井 淳, 松村 功貴, 村上 洋, 山下 真紀, 田辺 壽太郎, 村上 宏, 玉澤 直樹, 大門 眞

弘前医学   65 ( 1 )   35 - 42   2014

Reduction of paraoxonase-1 activity may contribute the qualitative impairment of HDL particles in patients with type 2 diabetes.

Murakami H, Tanabe J, Tamasawa N, Matsumura K, Yamashita M, Matsuki K, Murakami H, Matsui J, Suda T

Diabetes research and clinical practice   99 ( 1 )   30 - 8   2013.1

Reduced cellular cholesterol efflux and low plasma high-density lipoprotein cholesterol in a patient with type B Niemann-Pick disease because of a novel SMPD-1 mutation.

Tamasawa N, Takayasu S, Murakami H, Yamashita M, Matsuki K, Tanabe J, Murakami H, Matsui J, Satoh K, Suda T

Journal of clinical lipidology   6 ( 1 )   74 - 80   2012.1

Therapeutic Intervention Through PPARs in Glucose and Lipid Homeostasis Involving Obesity : Clinical Significance of PPARα・γ Dual Agonists

TAMASAWA N., TANABE J., MATSUI J., SUDA T.

Journal of the Japan Diabetes Society   54 ( 3 )   161 - 164   2011.3

Therapeutic Intervention Through PPARs in Glucose and Lipid Homeostasis Involving Obesity: Clinical Significance of PPAR<i>&alpha;</i>&middot;<i>&gamma;</i> Dual Agonists

Tamasawa N., Tanabe J., Matsui J., Suda T.

Journal of the Japan Diabetes Society   54 ( 3 )   161 - 164   2011

The Frequency of Type 2 Diabetic Patients who Meet the Endocrinological Screening Criteria of Subclinical Cushing's Disease

MURAKAMI HIROSHI, NIGAWARA TAKESHI, SAKIHARA SATORU, KAGEYAMA KAZUNORI, YAMASHITA MAKI, MATSUKI KOTA, TANABE JUTARO, MATSUI JUN, TAMASAWA NAOKI, SUDA TOSHIHIRO

Endocrine journal   57 ( 3 )   267 - 272   2010.3

Insulin Suppresses HDL-Mediated Cholesterol Efflux from Macrophages Through Inhibition of Neutral Cholesteryl Ester Hydrolase and ATP-Binding Cassette Transporter G1 Expressions

Yamashita Maki, Tamasawa Naoki, Matsuki Kota, Tanabe Jutaro, Murakami Hiroshi, Matsui Jun, Suda Toshihiro

Ｊｏｕｒｎａｌ　ｏｆ　Ａｔｈｅｒｏｓｃｌｅｒｏｓｉｓ　ａｎｄ　Ｔｈｒｏｍｂｏｓｉｓ   17 ( 11 )   1183 - 1189   2010

Metformin restores impaired HDL-mediated cholesterol efflux due to glycation.

Matsuki K, Tamasawa N, Yamashita M, Tanabe J, Murakami H, Matsui J, Imaizumi T, Satoh K, Suda T

Atherosclerosis   206 ( 2 )   434 - 8   2009.10

Time course of pain sensation in rat models of insulin resistance, type 2 diabetes, and exogenous hyperinsulinaemia.

Sugimoto K, Rashid IB, Kojima K, Shoji M, Tanabe J, Tamasawa N, Suda T, Yasujima M

Diabetes/metabolism research and reviews   24 ( 8 )   642 - 50   2008.11

A case of multiple endocrine neoplasia type II accompanied by thyroid medullary carcinoma and pheochromocytomas expressing corticotropin-releasing factor and urocortins.

Kageyama K, Sakihara S, Yamashita M, Takahashi K, Kawashima S, Tanabe J, Tsutaya S, Yasujima M, Suda T

The American journal of the medical sciences   335 ( 5 )   398 - 402   2008.5

HMG-CoA Reductase Inhibitor, Simvastatin Improves Reverse Cholesterol Transport in Type 2 Diabetic Patients with Hyperlipidemia

GUAN Jing-Zhi, TAMASAWA Naoki, MURAKAMI Hiroshi, MATSUI Jun, TANABE Jutaro, MATSUKI Kota, YAMASHITA Maki, SUDA Toshihiro

Journal of atherosclerosis and thrombosis   15 ( 1 )   20 - 25   2008.2

アンギオテンシノーゲン遺伝子235T alleleを有する2型糖尿病腎症患者におけるACE阻害剤とARB併用によるアルブミン尿改善効果

松井 淳, 小川 吉司, 玉澤 直樹, 山下 真紀, 松木 恒太, 田辺 壽太郎, 村上 宏, 須田 俊宏

弘前医学   59 ( 2 )   59 - 64   2008

HMG-CoA Reductase Inhibitor, Simvastatin Improves Reverse Cholesterol Transport in Type 2 Diabetic Patients with Hyperlipidemia

Guan Jing-Zhi, Tamasawa Naoki, Murakami Hiroshi, Matsui Jun, Tanabe Jutaro, Matsuki Kota, Yamashita Maki, Suda Toshihiro

Ｊｏｕｒｎａｌ　ｏｆ　Ａｔｈｅｒｏｓｃｌｅｒｏｓｉｓ　ａｎｄ　Ｔｈｒｏｍｂｏｓｉｓ   15 ( 1 )   20 - 25   2008

Effects of combined PPARgamma and PPARalpha agonist therapy on reverse cholesterol transport in the Zucker diabetic fatty rat.

Jutaro Tanabea, Naoki Tamasawaa, Maki Yamashitaa, Kota Matsukia, Hiroshi Murakamia, Jun Matsuia, Kazuhiro Sugimotob, Minoru Yasujimab, Toshihiro Sudaa

Diabetes, Obesity and Metabolism   10 ( 9 )   772 - 779   2007.3

Nicorandil, ATP-sensitive K<SUP>+</SUP> channel opener, does not interfere with sulfonylureas and nateglinide in patients with type 2 diabetes

Matsuki Kota, Tanabe Jutaro, Yanagimachi Miyuki, Murakami Hiroshi, Tando Yusuke, Matsui Jun, Ogawa Yoshiji, Tamasawa Naoki, Suda Toshihiro

Shinzo   39 ( 8 )   715 - 719   2007

Glucose-stimulated insulin response in non-diabetic patients with lipoprotein lipase deficiency and hypertriglyceridemia.

Tamasawa N, Matsui J, Murakami H, Tanabe J, Matsuki K, Ogawa Y, Ikeda Y, Takagi A, Suda T

Diabetes research and clinical practice   72 ( 1 )   6 - 11   2006.4

Clinical characteristics of Japanese youth-onset type 2 diabetes with ketonuria.

Matsui J, Tamasawa N, Tanabe J, Kasai N, Murakami H, Matsuki K, Suda T

Diabetes research and clinical practice   70 ( 3 )   235 - 8   2005.12

Evaluation of apolipoprotein E secretion by macrophages in type 2 diabetic patients: role of HDL and apolipoprotein A-I.

Yamato K, Tamasawa N, Murakami H, Matsui J, Tanabe J, Suda T, Yasujima M

Diabetes research and clinical practice   69 ( 2 )   124 - 8   2005.8

LDL particle size and lipid composition are risk factors for microalbuminuria in normotensive and normocholesterolemic patients with type 2 diabetes.

Matsui J, Tamasawa N, Tanabe J, Kasai N, Murakami H, Yamato K, Guan J, Suda T

Diabetes research and clinical practice   66 ( 3 )   229 - 36   2004.12

Effects of Fluvastatin in Type 2 Diabetic Patients with Hyperlipidemia : Reduction in Cholesterol Oxidation Products and VCAM-1

GUAN Jing-Zhi, MURAKAMI Hiroshi, YAMATO Kazumi, TANABE Jutaro, MATSUI Jun, TAMASAWA Naoki, SUDA Toshihiro

Journal of atherosclerosis and thrombosis   11 ( 2 )   56 - 61   2004.4

EFFECT OF FENOFIBRATE ON LIPID LEVELS OF TYPE 2 DIABETIC PATIENTS WITH DYSLIPIDEMIA

村上 宏, 玉澤 直樹, 大和 一美, 田辺 壽太郎, 葛西 伸彦, 松井 淳, 管 静芝, 小川 吉司, 須田 俊宏

弘前医学   55 ( 3 )   101 - 107   2004.3

Effects of Fluvastatin in Type 2 Diabetic Patients with Hyperlipidemia: Reduction in Cholesterol Oxidation Products and VCAM-1

Guan Jing-Zhi, Murakami Hiroshi, Yamato Kazumi, Tanabe Jutaro, Matsui Jun, Tamasawa Naoki, Suda Toshihiro

Ｊｏｕｒｎａｌ　ｏｆ　Ａｔｈｅｒｏｓｃｌｅｒｏｓｉｓ　ａｎｄ　Ｔｈｒｏｍｂｏｓｉｓ   11 ( 2 )   56 - 61   2004

A case of chronic pancreatitis with a latent deficiency of vitamin E

YANAGIMACHI Miyuki, MATSUHASHI Yuki, TADANO Yusuke, SUDA Toshihiro, NAKAMURA Teruo, WATANABE Taku

17 ( 1 )   46 - 50   2002.2